Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EQ Inc. Capital/Financing Update 2021

Feb 3, 2021

43758_rns_2021-02-03_0c0635c8-76ee-4f1f-8aa9-6a6ad5cce824.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [99 x 58] intentionally omitted <==

EQ Inc. Public Offering of Common Shares C$■ February 3, 2021

A preliminary short form prospectus containing important information relating to the securities described in this document has been filed with the securities regulatory authorities in all of the Provinces of Canada (except Quebec). A copy of the preliminary short form prospectus, and any amendment, is required to be delivered with this document. The preliminary prospectus is still subject to completion. There will not be any sale or any acceptance of an offer to buy the securities until a receipt for the final short form prospectus has been issued. This document does not provide full disclosure of all material facts relating to the securities offered. Investors should read the preliminary short form prospectus, final short form prospectus and any amendment for disclosure of those facts, especially risk factors relating to the securities offered, before making an investment decision.

Issuer: EQ Inc. (the “Company”).
Offering: ■common shares (a “Common Share”) in the capital of the Company (the “Offered
Securities”).
Gross Proceeds: C$■(the “Offering”).
Issue Price: C$■per Offered Security.
Over-Allotment Option: The Company has granted the underwriters an option (the “Over-Allotment Option”),
exercisable, in whole or in part, by Canaccord Genuity Corp., on behalf of the
underwriters, at any time and from time to time up to 30 days following the Closing
Date (as defined below), to purchase up to an additional number of Offered
Securities (the “Additional Offered Securities”) in an amount equal to 15% of the
Offered Securities sold pursuant to the Offering at a price per Additional Offered
Security equal to the Issue Price to cover overallotments, if any, and for market
stabilization purposes. All references herein to the “Offering” shall be deemed to
include the Over-Allotment Option and all references herein to the “Offered
Securities” shall be deemed to include the Additional Offered Securities. For
certainty, the Over-Allotment Option shall be exercisable for Additional Offered
Securities.
Use of Proceeds: The net proceeds from the Offering will be used to develop its proprietary SaaS
platform, marketing and branding initiatives, research and development, expansion
into the United States and for working capital and general corporate purposes.
Form of Offering: Short form prospectus offering in all of the Provinces of Canada (except Quebec) and
in the United States to Qualified Institutional Buyers (as defined in Rule 144A under
the United States Securities Act of 1933, as amended (the “1933 Act”)) by way of
private placement pursuant to an available exemption from the registration
requirements of the 1933 Act and similar exemptions under applicable state
securities laws, and by private placement to eligible purchasers resident in
jurisdictions other than Canada and the U.S.

Eligibility: The Offered Securities are expected to be eligible for RRSPs, RRIFs, RDSPs, RESPs, TFSAs and DPSPs.

==> picture [134 x 45] intentionally omitted <==

Listing: The Company shall obtain the necessary approvals to list the Offered Securities under the Company’s trading symbol “EQ” on the TSX Venture Exchange, which listing shall be conditionally approved prior to the Closing Date. Lead Underwriter : Canaccord Genuity Corp. Underwriters’ Compensation: 6% cash fee (the “ Underwriters’ Fee ”); 6% compensation options (the “ Compensation Options ”) exercisable into Offered Securities at the Issue Price for 18 months following the Closing Date; provided, however, that the Underwriters’ Fee shall be equal to 3% in respect of persons or entities included on the “President’s List” and no Compensation Options shall be issued in respect of such persons or entities. Closing Date: On or about February 19, 2021 or such other date as mutually agreed to between Canaccord Genuity Corp. and the Company, each acting reasonably.

==> picture [134 x 45] intentionally omitted <==